Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Biochemical Pharmaceutical is a prominent Chinese pharmaceutical manufacturer specializing in the production of biochemical drugs, including hormones, enzymes, and peptides. As a subsidiary of the Tianjin Pharmaceutical Group (TJPH), the company operates large-scale manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards. Its product portfolio features essential medicines such as insulin, oxytocin, and various cardiovascular treatments. The company plays a critical role in the domestic Chinese healthcare market by providing high-quality, affordable biochemical therapeutics and active pharmaceutical ingredients (APIs).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Biochemical Pharmaceutical.